Participants Required For Men’s Testosterone Study

Categories: ,

Group of men.

Professor David J Handelsman (Andrology Dept, Concord Hospital, ANZAC Research Institute, Sydney) is looking to recruit 15 healthy male volunteers to participate in a new testosterone study titled ‘Pharmacokinetics of Testosterone Cream Applied to Scrotal Skin’

The conventional use of testosterone cream, gel and solutions has been to the upper body in testosterone deficient men. Due to low absorption rates residual testosterone can be transferred to partners and children via contact with the skin to which the testosterone has been applied. This study will examine the absorption of testosterone cream when applied to scrotal skin which opens the potential to avoid passive transfer problems.

The study is seeking 15 men that meet the following criteria;

  • healthy and aged between 18 and 50
  • able to make 5 visits within a 12 day period, including 3 x 16 hour visits to the clinic
  • have normal reproductive endocrine function.

If you are interested in participating please complete this screening questionnaire link www.lawleypharm.com.au/tstudy.php.

Participants will be compensated for their time and travel expenses at the end of participating in the study.

Latest News


Mindfulness May Help Lower Sexual Distress in Older Women With Low Libido Mindfulness May Help Lower Sexual Distress in Older Women With Low Libido

International Society For Sexual Medicine Mindfulness May Help Lower Sexual Distress in Older Women With Low Libido    

NEW IMS Symposium with Dr James Simon & Sharon Parish NEW IMS Symposium with Dr James Simon & Sharon Parish

Sexual Health and Treatment for Women: Fact, Fiction, the Future. At the International Menopause Society’s 19th World Congress on Menopause to be held 19th – 22nd October 2024 in… Continue Reading →

INTERNATIONAL RECOGNITION PROCEDURE OFFERS HOPE FOR UK’S POSTMENOPAUSAL WOMEN. INTERNATIONAL RECOGNITION PROCEDURE OFFERS HOPE FOR UK’S POSTMENOPAUSAL WOMEN.

Hypoactive Sexual Desire Dysfunction (HSDD) Perth, Australia: Lawley Pharmaceuticals, via UK-based commercial partner, Andro Pharmaceuticals Ltd, today submitted a Marketing Authorisation Application (MAA) for… Continue Reading →